• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints

New Amgen obesity drug data disappoint Wall Street

Simon Osuji by Simon Osuji
June 25, 2025
in Technology
0
New Amgen obesity drug data disappoint Wall Street
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss effects that weren’t as strong as previously reported.

Related posts

FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo

FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo

March 6, 2026
Innovator unveils tool to encourage careers in sustainable development – EnviroNews

Innovator unveils tool to encourage careers in sustainable development – EnviroNews

March 6, 2026

Source link

Previous Post

Zamfara govt refutes claim of receiving $21mln loan

 Next Post

Nigeria Unveils Hexacopter Drone With Automatic Rifle
Next Post
Nigeria Unveils Hexacopter Drone With Automatic Rifle

Nigeria Unveils Hexacopter Drone With Automatic Rifle

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Germany Opens NATO Naval Command Center on Baltic Sea

Germany Opens NATO Naval Command Center on Baltic Sea

1 year ago
Otsuka’s startup bet pays off with kidney disease drug results

Otsuka’s startup bet pays off with kidney disease drug results

1 year ago
Microsoft’s Activision Blizzard Deal Changes the Game

Microsoft’s Activision Blizzard Deal Changes the Game

2 years ago
Perenco deal at risk, Bowleven’s top shareholder warns

Perenco deal at risk, Bowleven’s top shareholder warns

2 years ago

POPULAR NEWS

  • Mahama attends Liberia’s 178th independence anniversary

    Mahama attends Liberia’s 178th independence anniversary

    0 shares
    Share 0 Tweet 0

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0

  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0

  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0

  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.